Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

First, let’s take a look at the private biotech investments in March 2025, breaking them down by value, location, funding type, and therapeutic subsector. In March 2025, drug discovery company ...

Worldwide adult obesity has more than doubled since 1990, and, even more shockingly, adolescent obesity has quadrupled, becoming an ever-growing health threat. The latest figures from the World Health ...

Gene therapy represents a transformative approach in modern medicine, with the potential to address and cure a wide array of genetic disorders. By introducing, modifying, or repairing genetic material ...

While Finland’s biotech isn’t focused solely on health and contributes to the fields of food or sustainability with companies like Solar Foods or Metgen, healthcare remains a strong component of the ...